| Dr Rafael F Cardona Duran, MD | |
|
Carr 199 Km 12 Ave Las Cumbres, Professional Hospital, Guaynabo, PR 00965 | |
| (787) 243-7080 | |
| (888) 373-4866 |
| Full Name | Dr Rafael F Cardona Duran |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | Carr 199 Km 12 Ave Las Cumbres, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396948840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 13634 (Puerto Rico) | Primary |
| Entity Name | Puerto Rico Neurological Spine Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144533746 PECOS PAC ID: 3375736143 Enrollment ID: O20101025001124 |
News Archive
The aim is to identify precisely the one drug, or the correct combination of drugs, that are most effective against the specific tumor present in each patient. Professor hopes that new tools will come into use in the next five years.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
The deadline for states to inform the federal government if they would operate healthcare exchanges under President Barack Obama's healthcare reform law was December 14.
As the coronavirus pandemic continues to wreak havoc across the globe, there is a dire need for effective and safe therapeutics and vaccines. Overall, the pandemic has infected more than 90.87 million people and taken more 1.94 million lives.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rafael F Cardona Duran, MD 96 Calle Tulip Urb. Monte Verde Real, San Juan, PR 00926-5930 Ph: (787) 243-7080 | Dr Rafael F Cardona Duran, MD Carr 199 Km 12 Ave Las Cumbres, Professional Hospital, Guaynabo, PR 00965 Ph: (787) 243-7080 |
News Archive
The aim is to identify precisely the one drug, or the correct combination of drugs, that are most effective against the specific tumor present in each patient. Professor hopes that new tools will come into use in the next five years.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
The deadline for states to inform the federal government if they would operate healthcare exchanges under President Barack Obama's healthcare reform law was December 14.
As the coronavirus pandemic continues to wreak havoc across the globe, there is a dire need for effective and safe therapeutics and vaccines. Overall, the pandemic has infected more than 90.87 million people and taken more 1.94 million lives.
› Verified 9 days ago